Traders should monitor for upcoming earnings or clinical trial updates, as this level of coordinated insider selling may suggest lack of confidence in near-term catalysts. Watch for Form 4 filings to confirm whether these were pre-arranged 10b5-1 plans or discretionary trades.
Price Chart
Executive Summary
Multiple C-suite executives at Vir Biotechnology, including the CEO, CMO, and General Counsel, sold shares worth over $191K in the past week. These sales follow a pattern of insider selling in the last 30 days and involve material dollar amounts, though they are not accompanied by any public financial disclosures or news that would explain the timing.
Key Financial Metrics
Key Facts
- CEO Marianne De Backer sold $141,894 worth of shares in a single transaction on February 23, 2026.
- EVP Vanina de Verneuil and CMO Mark Eisner also sold $33,128 and $15,569 worth of shares, respectively, on the same day.
- All three insiders also had option awards (A) totaling 138,000 shares on February 22, which were granted at $0, indicating a routine award or exercise unrelated to trading activity.
- No insider purchases were reported in the cluster — only sales by top executives.
- Recent insider activity over the past 30 days includes three additional sells totaling $191K, showing a consistent trend of insider divestment.
Financial Impact
Total insider sales: $191K in the past 7 days, all from senior executives.
Risk Factors
- Insider selling could signal negative non-public information, especially when concentrated among C-suite executives.
- Potential for negative sentiment impact ahead of earnings or clinical data readouts if no positive catalyst emerges.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (6 trades, 7d window) | cluster-VIR-1771978337169 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Court Ruling | $9.24 $9.78 | ▲ +5.84% | ▲ +7.21% | $11.17 (+20.89%) |
Aug 9, 2026 7w ago | Institutional Cluster | $8.89 $9.39 | ▲ +5.62% | ▲ +5.67% | $11.17 (+25.65%) |
Jul 24, 2026 10w ago | 8-K | $8.69 $8.90 | ▲ +2.42% | ▲ +2.04% | $11.17 (+28.54%) |
Jun 29, 2026 13w ago | 144 | $10.38 $10.02 | ▼ −3.47% | ▼ −4.86% | $11.17 (+7.61%) |
Jun 10, 2026 16w ago | 3 | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 10, 2026 16w ago | 8-K | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 2, 2026 17w ago | Insider Cluster | $8.77 $8.25 | ▼ −5.93% | ▼ −2.11% | $11.17 (+27.37%) |
May 28, 2026 18w ago | 8-K | $9.55 $8.77 | ▼ −8.17% | ▼ −8.12% | $11.17 (+16.96%) |
Apr 16, 2026 24w ago | DEFA14A | $10.33 $10.35 | ▲ +0.19% | ▼ −0.79% | $11.17 (+8.13%) |
Apr 10, 2026 25w ago | 8-K | $9.31 $11.09 | ▲ +19.12% | ▲ +15.82% | $11.17 (+19.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access